Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01671566
Other study ID # GUCHUmU01
Secondary ID
Status Completed
Phase N/A
First received August 20, 2012
Last updated March 3, 2016
Start date September 2012
Est. completion date March 2016

Study information

Verified date March 2016
Source Umeå University
Contact n/a
Is FDA regulated No
Health authority Sweden: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Adults with congenital heart disease have various degrees of impaired exercise capacity compared to healthy controls. Impaired exercise capacity makes everyday activities more difficult and demanding. There are few studies on effect of exercise training in adults with congenital heart disease. The hypothesis of this study is that structured home based exercise training will improve exercise capacity and health status in the studied population.


Description:

The number adults with congenital heart disease is increasing. Thanks to advances in the medical and surgical fields the number of adults with complex congenital heart disease is now higher than the children with corresponding heart disease. Though the long term prognosis is still unknown and continuously changing as new therapeutic options are introduced.

Persons with congenital heart disease have different degrees of impaired exercise capacity compared to healthy controls. Some studies indicate that this population is not sufficiently active to achieve the recommendations for physical activity in preventing acquired heart disease. Physical inactivity is an important risk factor for developing acquired heart disease and other life style diseases as obesity and diabetes. In a population where one or more previous cardiac surgeries are common, the prevention of life style diseases is especially important. Exercise training in heart failure and coronary artery disease is well studied and there are clinical guidelines. Regarding exercise training in adults with congenital heart disease, however,the information is sparse and further studies are needed.

Based on defined inclusion and exclusion criteria adults with complex congenital heart disease will be recruited in the Northern Health Care Region in Sweden and in Gothenburg. Before and after the twelve week intervention period the investigators will collect information about cardiopulmonary exercise capacity, health related quality of life, exercise self-efficacy, anxiety and depression. The patients will be randomized to twelve weeks of home based interval training or to a control group. The randomization ratio will be 2:1 (intervention:control). The control group will be instructed to continue with their habitual physical activities. The home based interval training program will be individualized based on the results of the exercise tests.

The aim of this study is to examine the effect of home based interval training on maximal and submaximal exercise capacity, quality of life, exercise self-efficacy, anxiety and depression.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date March 2016
Est. primary completion date March 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Complex congenital heart disease (e.g.; Tetralogy of Fallot, Transpositions of the great arteries, Ebstein, Eisenmenger, Pulmonary atresia or Tricuspid atresia)

- Clinically stable without significant change the last 3 months

- Adult (>18 years)

- Informed consent

Exclusion Criteria:

- Signs of arrhythmia on exercise ECG or relevant clinical arrhythmia

- Mental retardation or psychiatric illness affecting the ability of independent decisions

- Other comorbidity affecting physical activity

- Other circumstances making participation unsuitable

- Present strategy of regularly executing physical exercise > 2 times/week in purpose to increase cardiovascular capacity.

- VO2 peak > 30 ml/kg/min

- No access to internet

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)


Intervention

Behavioral:
Home based interval training
The participant in the intervention group will receive an individualized interval training program. The individualized adjustments in training load will be made from the results of the CPET-incremental and adjustments in training time from the results of the constant work rate 75% of peak work rate (Watt). The training will be home based and performed on a ergometer cycle 3 times a week for twelve weeks. During exercise they will wear a heart rate monitoring watch. The registered heart rate will be transferred to a webpage after the exercise session. Only the physiotherapist and participant have the access to this page. The physiotherapist and participant will have a weekly contact to promote compliance, provide feedback and if necessary adjust the training time or load. Progression in training load and time will be made when necessary to keep a relevant intensity.

Locations

Country Name City State
Sweden Sahlgrenska University hospital Gothenburg
Sweden University Hospital Umeå

Sponsors (1)

Lead Sponsor Collaborator
Umeå University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Peak VO2 (ml/kg/min) Comparison within and between groups Before homebased interval exrecise regime and after completion (12 weeks) No
Primary Endurance time at CPET-incremental and constant work rate test at 75% of peak work rate (Watt). Comparison between and within groups. Before homebased interval exercise regimen and at completion (12 weeks) No
Secondary Response during CPET incremental and constant work rate test at 75% of peak work rate (Watt). (Peak VO2 (l/min) and Iso time, VCO2, VE/VCO2, VE/VCO2-slope, anaerobic threshold, Peak Heart Rate, Heart Rate recovery, Heart Rate response, Peak work rate, Oxygen saturation, Blood pressure, symptoms) Comparison within and between groups. Before homebased interval exercise regime and at completion (12 weeks) No
Secondary Adverse events Complications to training Once a week during homebased exercise regime Yes
Secondary Quality of life The EQ-5D and SF 36 questionaires will be used to assess Quality of life. Comparison between and within groups. Before homebased interval exercise regime and at completion (12 weeks) No
Secondary Physical activity level The long self administered version of International Physical Activity Questionaire (IPAQ) will be used to assess physical activity level. Comparison within and between groups. Before homebased interval exercise regime and after completion (12 weeks) No
Secondary Exercise self-efficacy The Exercise Self-Efficacy Scale will be used. Comparison within and between groups Before homebased interval exercise regime and after completion No
Secondary Anxiety and depression The hospital anxiety and depression scale (HAD-scale) will be used to estimate the incidence of anxiety and depression. Comparison between and within groups. Before homebased interval exercise regime and after completion (12 weeks) No
Secondary Response during CPET incremental and constant work rate test at 75 % of peak work rate (Watt). ( Peak VO2 and Iso time(l/min), VCO2, VE/VCO2, VE/VCO-slope, anaerobic threshold, Peak Heart Rate, Heart Rate recovery, Heart rate response, Peak work rate, Oxygen saturation, Blood pressure, symptoms) Comparison within and between groups. 12 months after completion No
Secondary Peak VO2( ml/kg/min) Comparison within and between groups 12 months after completion No
Secondary Endurance time at CPET incremental and constant work rate at 75% of peak work rate (Watt) 12 months after completion No
Secondary Quality of life The EQ-5D and SF 36 questionaires will be used to assess Quality of life. Comparison within and between groups. 12 months after completion No
Secondary Physical Activity level The long self administered version of International Physical Activity Questionaire (IPAQ) will be used to assess physical activity level. Comparison within and between groups. 12 months after completion No
Secondary Anxiety and depression The hospital Anxiety and Depression Scale (HAD-scale) will be used to estimate the incidence of anxiety and depression. Comparison within and between groups. 12 months after completion No
See also
  Status Clinical Trial Phase
Recruiting NCT01421030 - Outcomes in Patients and Their Closest Relatives Treated for Congenital Heart Disease With Catheter Based or Surgical Techniques Phase 0
Completed NCT01567579 - An Evaluation of Routine Developmental Follow-Up in Infants and Children With Congenital Heart Disease
Withdrawn NCT00981591 - Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients Phase 1/Phase 2
Terminated NCT00208676 - Using Tissue Doppler/Synchronization to Determine Heart Function in Children With Congenital Heart Disease N/A
Completed NCT01941576 - Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot N/A
Completed NCT01475357 - Intestinal Function in Neonates With Complex Congenital Heart Disease N/A
Active, not recruiting NCT01227096 - Randomized Controlled Trial of the Effects of Electroacupuncture Preconditioning in Children Undergoing Cardiac Surgery N/A
Completed NCT01201486 - Use of Color Doppler in Routine Examination of Fetal Heart in Second Trimester N/A
Completed NCT00397514 - Assessing the Hemodynamic Benefits of Cardiac Resynchronization Therapy in Children Following Open-Heart Surgery N/A
Completed NCT02232399 - Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease? Phase 2
Completed NCT05191654 - Investigation of Cardiopulmonary Parameters, Motor Development and Muscle Strength in DS With and Without CHD
Recruiting NCT06267859 - Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children Early Phase 1
Completed NCT02320669 - Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass Phase 3
Completed NCT01489475 - Plasma Angiopoietin Levels in Children Following Cardiopulmonary Bypass N/A
Withdrawn NCT00579358 - Molecular Basis of Congenital Heart Defects
Recruiting NCT01196182 - Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
Recruiting NCT03822442 - MRI to Predict Rejection and Failure in Transplant and Cardiomyopathy Patients
Recruiting NCT04382573 - Better Delineation of CDK13 Related Phenotype and Epigenetic Signature.
Completed NCT00450684 - Cardiac Resynchronization Therapy in Congenital Heart Defects Phase 2/Phase 3
Terminated NCT00208754 - Heart Failure in Adult Patients With a History of Congenital Heart Disease N/A